Table 2.
Markers of oxidative stress and inflammation
| Markers | Control | Diabetic | VC treated |
| MPO (µmol/mL/mg protein) | 1.63 ± 0.3 | 2.3 ± 0.07a | 1.62 ± 0.31 |
| NO (M/dL) | 9.5 ± 0.3 | 20.1 ± 0.6b | 8.7 ± 1.11 |
| SOD (unit SOD/min) | 0.7 ± 0.1 | 1.4 ± 0.04b | 0.6 ± 0.11 |
| LPO (nmol/mg protein) | 8.1 ± 1.0 | 16.4 ± 1.2b | 8.6 ± 0.71 |
| GSH (mg/dL) | 11.3 ± 1.0 | 5.89 ± 0.8b | 9.2 ± 1.91 |
| AA (µg/mL) | 61 ± 10.6 | 39.2 ± 2.0b | 62.3 ± 6.21 |
Results are mean ± SE, n = 10;
1
No significant difference from control;
a
P < 0.05,
b
P < 0.01, significantly different from control. MPO: Myeloperoxidase; NO: Nitric oxide; SOD: Super oxide dismutase; MDA: Malondialdehyde; GSH: Glutathione; AA: Ascorbic acid.